Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats

Objective Dapsone (diaminodiphenyl sulfone, DDS) is currently used to treat leprosy, malaria, dermatitis herpetiformis, and other diseases. It is also used to treat pneumocystis pneumonia and Toxoplasma gondii infection in HIV-positive patients. The most common adverse effect of DDS is methemoglobin...

Full description

Bibliographic Details
Main Authors: Changwoo Kang, Dong Hoon Kim, Taeyun Kim, Soo Hoon Lee, Jin Hee Jeong, Sang Bong Lee, Jin Hyun Kim, Myeong Hee Jung, Kyung-woo Lee, In Sung Park
Format: Article
Language:English
Published: The Korean Society of Emergency Medicine 2018-09-01
Series:Clinical and Experimental Emergency Medicine
Subjects:
Online Access:http://www.ceemjournal.org/upload/pdf/ceem-17-253.pdf
_version_ 1797895595123277824
author Changwoo Kang
Dong Hoon Kim
Taeyun Kim
Soo Hoon Lee
Jin Hee Jeong
Sang Bong Lee
Jin Hyun Kim
Myeong Hee Jung
Kyung-woo Lee
In Sung Park
author_facet Changwoo Kang
Dong Hoon Kim
Taeyun Kim
Soo Hoon Lee
Jin Hee Jeong
Sang Bong Lee
Jin Hyun Kim
Myeong Hee Jung
Kyung-woo Lee
In Sung Park
author_sort Changwoo Kang
collection DOAJ
description Objective Dapsone (diaminodiphenyl sulfone, DDS) is currently used to treat leprosy, malaria, dermatitis herpetiformis, and other diseases. It is also used to treat pneumocystis pneumonia and Toxoplasma gondii infection in HIV-positive patients. The most common adverse effect of DDS is methemoglobinemia from oxidative stress. Ascorbic acid is an antioxidant and reducing agent that scavenges the free radicals produced by oxidative stress. The present study aimed to investigate the effect of ascorbic acid in the treatment of DDS induced methemoglobinemia. Methods Male Sprague-Dawley rats were divided into three groups: an ascorbic acid group, a methylene blue (MB) group, and a control group. After DDS (40 mg/kg) treatment via oral gavage, ascorbic acid (15 mg/kg), MB (1 mg/kg), or normal saline were administered via tail vein injection. Depending on the duration of the DDS treatment, blood methemoglobin levels, as well as the nitric oxide levels and catalase activity, were measured at 60, 120, or 180 minutes after DDS administration. Results Methemoglobin concentrations in the ascorbic acid and MB groups were significantly lower compared to those in the control group across multiple time points. The plasma nitric oxide levels and catalase activity were not different among the groups or time points. Conclusion Intravenous ascorbic acid administration is effective in treating DDS-induced methemoglobinemia in a murine model.
first_indexed 2024-04-10T07:29:26Z
format Article
id doaj.art-116c2b304e434fb08c50d3cd27c122aa
institution Directory Open Access Journal
issn 2383-4625
language English
last_indexed 2024-04-10T07:29:26Z
publishDate 2018-09-01
publisher The Korean Society of Emergency Medicine
record_format Article
series Clinical and Experimental Emergency Medicine
spelling doaj.art-116c2b304e434fb08c50d3cd27c122aa2023-02-24T01:32:12ZengThe Korean Society of Emergency MedicineClinical and Experimental Emergency Medicine2383-46252018-09-015319219810.15441/ceem.17.253195Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in ratsChangwoo Kang0Dong Hoon Kim1Taeyun Kim2Soo Hoon Lee3Jin Hee Jeong4Sang Bong Lee5Jin Hyun Kim6Myeong Hee Jung7Kyung-woo Lee8In Sung Park9 Department of Emergency Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea Department of Emergency Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea Department of Emergency Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea Department of Emergency Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea Department of Emergency Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea Department of Emergency Medicine, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea Institute of Health Sciences, Gyeongsang National University, Jinju, Korea Biomedical Research Institute, Gyeongsang National University Hospital, Jinju, Korea Department of Emergency Medicine, Catholic University of Daegu, Daegu, Korea Institute of Health Sciences, Gyeongsang National University, Jinju, KoreaObjective Dapsone (diaminodiphenyl sulfone, DDS) is currently used to treat leprosy, malaria, dermatitis herpetiformis, and other diseases. It is also used to treat pneumocystis pneumonia and Toxoplasma gondii infection in HIV-positive patients. The most common adverse effect of DDS is methemoglobinemia from oxidative stress. Ascorbic acid is an antioxidant and reducing agent that scavenges the free radicals produced by oxidative stress. The present study aimed to investigate the effect of ascorbic acid in the treatment of DDS induced methemoglobinemia. Methods Male Sprague-Dawley rats were divided into three groups: an ascorbic acid group, a methylene blue (MB) group, and a control group. After DDS (40 mg/kg) treatment via oral gavage, ascorbic acid (15 mg/kg), MB (1 mg/kg), or normal saline were administered via tail vein injection. Depending on the duration of the DDS treatment, blood methemoglobin levels, as well as the nitric oxide levels and catalase activity, were measured at 60, 120, or 180 minutes after DDS administration. Results Methemoglobin concentrations in the ascorbic acid and MB groups were significantly lower compared to those in the control group across multiple time points. The plasma nitric oxide levels and catalase activity were not different among the groups or time points. Conclusion Intravenous ascorbic acid administration is effective in treating DDS-induced methemoglobinemia in a murine model.http://www.ceemjournal.org/upload/pdf/ceem-17-253.pdfmethemoglobinascorbic acidmethylene blueanti-oxidation
spellingShingle Changwoo Kang
Dong Hoon Kim
Taeyun Kim
Soo Hoon Lee
Jin Hee Jeong
Sang Bong Lee
Jin Hyun Kim
Myeong Hee Jung
Kyung-woo Lee
In Sung Park
Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats
Clinical and Experimental Emergency Medicine
methemoglobin
ascorbic acid
methylene blue
anti-oxidation
title Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats
title_full Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats
title_fullStr Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats
title_full_unstemmed Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats
title_short Therapeutic effect of ascorbic acid on dapsone-induced methemoglobinemia in rats
title_sort therapeutic effect of ascorbic acid on dapsone induced methemoglobinemia in rats
topic methemoglobin
ascorbic acid
methylene blue
anti-oxidation
url http://www.ceemjournal.org/upload/pdf/ceem-17-253.pdf
work_keys_str_mv AT changwookang therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats
AT donghoonkim therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats
AT taeyunkim therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats
AT soohoonlee therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats
AT jinheejeong therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats
AT sangbonglee therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats
AT jinhyunkim therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats
AT myeongheejung therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats
AT kyungwoolee therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats
AT insungpark therapeuticeffectofascorbicacidondapsoneinducedmethemoglobinemiainrats